The financials
Cardinal Health by the numbers
Cardinal Health (CAH) reported revenue of $124.6B in H2 2026 (quarter ended Jun 30, 2026), up 127% from the same quarter a year earlier. That came with a gross margin of 4.1% and net income of $797M (0.6% of revenue). For the full year FY2026, revenue was $254.2B (+14% year on year) and net income $1.71B. Its largest segment in H2 2026 was Pharmaceutical And Specialty Solutions at $58.8B, 94% of the disclosed total, well ahead of GMPD at 5.0%.
| Income statement | H2 2026 | Q3 2025 | Change |
|---|---|---|---|
| Revenue | $124.6B | $54.9B | +127% |
| Gross profit | $5.06B | $2.12B | +138% |
| Operating income | $1.24B | $730M | +70% |
| Net income | $797M | $506M | +58% |
| Diluted EPS | n/a | $2.10 | n/a |
| Operating | Revenue | Share |
|---|---|---|
| Pharmaceutical And Specialty Solutions | $58.8B | 94% |
| GMPD | $3.13B | 5.0% |
| All Other | $497M | 0.8% |
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: H2 2026Total $62.47B (+4.6%)
All Other grew +16% year on yearGMPD -2.2% year on year
Segment Latestquarter on quarteryear on year
- Pharmaceutical And Specialty Solutions$58.85B$58.85BQoQ +4.9%year on year +6.3%+4.9%+6.3%
- GMPD$3.13B$3.13BQoQ -0.64%year on year -2.2%-0.64%-2.2%
- All Other$497.0M$497.0MQoQ +4.0%year on year +16%+4.0%+16%
Healthcare
Ranks #103 of 345 by Smart Score